We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Leptin Levels Linked to Cardiovascular Disease Risk

By Biotechdaily staff writers
Posted on 07 Oct 2002
A study has found that elevated levels of the leptin hormone in obese individuals cause decreased elasticity (distensibility) in blood vessel walls and may be partially responsible for the higher incidences of cardiovascular disease in overweight persons. The study was published September 23, 2002, in the online edition of Circulation.

Researchers from the MRC Childhood Nutrition Research Center (London, UK) studied a group of 249 teenagers, including some who were overweight but otherwise healthy. The investigators performed noninvasive ultrasound tests to examine arteries, measure blood pressure, blood cholesterol, glucose, leptin and the inflammation marker C-reactive protein (CRP). The average leptin level was 2.8 µmol/L for boys and 10.2 µmol/L for girls.

The data collected revealed a strong inverse relationship between arterial distension and leptin concentrations. A 10% increase in leptin concentration was associated with a 1.3% decrease in arterial distension. This association was independent of fat mass, blood pressure, and C-reactive protein, fasting insulin, or LDL cholesterol concentrations.

"Our study suggests a way in which obesity decreases the elasticity of blood vessels, thus increasing the risk of heart disease,” explained first author Dr. Atul Singhal, deputy director of nutrition at the MRC Childhood Nutrition Research Center. "Preventing even moderate fatness in childhood may have a long-term benefit for the risk of heart disease.”




Related Links:
MRC Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Immunofluorescence Analyzer
IFA System
Clinical Informatics Platform
CLARION™

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
07 Oct 2002  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
07 Oct 2002  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
07 Oct 2002  |   BioResearch